Results 1 to 10 of about 99,420 (208)

Acute graft versus host disease [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2007
Acute graft-versus-host disease (GVHD) occurs after allogeneic hematopoietic stem cell transplant and is a reaction of donor immune cells against host tissues. Activated donor T cells damage host epithelial cells after an inflammatory cascade that begins with the preparative regimen. About 35%-50% of hematopoietic stem cell transplant (HSCT) recipients
Georgia B. Vogelsang, David A. Jacobsohn
openaire   +5 more sources

NOTCH and Graft-Versus-Host Disease [PDF]

open access: yesFrontiers in Immunology, 2018
In allogeneic hematopoietic stem cell transplantation, which is the major curative therapy for hematological malignancies, T cells play a key role in the development of graft-versus-host disease (GvHD). NOTCH pathway is a conserved signal transduction system that regulates T cell development and differentiation.
Mauro Di Ianni   +15 more
openaire   +6 more sources

Human Graft Versus Host Disease

open access: bronzeJournal of Investigative Dermatology, 1980
Human graft versus host disease is composed of 2 distinct clinical entities, acute graft versus host disease and chronic graft versus host disease, which have different pathogenesis. Acute graft versus host disease is produced by the attack of donor immunocompetent T or null lymphocytes against recipient histocompatibility antigens.
Joel M. Rappeport   +2 more
openaire   +4 more sources

GRAFT-VERSUS-HOST DISEASE

open access: bronzeTransplantation, 1968
Graft-versus-host disease was induced in adult hybrid rats by injection of spleen cells from either or both parental strains. Under the conditions of these experiments, GVH disease infiltrates appeared in the hepatic portal areas in all rats splenectomized before injection, but rarely in intact or sham-operated animals.
Seymour Levine
openaire   +3 more sources

Graft-versus-host disease [PDF]

open access: yesCase Reports, 2010
This article presents the case of a 26-year-old man who was diagnosed with pneumatosis cystoides intestinalis, a rare consequence of colonic graft-versus-host disease, after CT imaging revealed free air tracking within the bowel wall and abdomen. His presentation with hiccups, abdominal and neck distension, along with diarrhoea was also unusual, and ...
Satyajit Sahu   +4 more
openaire   +5 more sources

Graft-Versus-Host Disease

open access: yesHematology/Oncology Clinics of North America, 1990
Graft-versus-host disease (GVHD) is caused by immunologic recognition of the patient by the donor marrow graft after allogeneic bone marrow transplantation. Despite advances in understanding and new agents and methods to treat GVHD, the disease and complications related to it and its treatment are the principal causes of death after transplantation ...
Georgia B. Vogelsang, John E. Wagner
openaire   +5 more sources

Graft-versus-host disease [PDF]

open access: yesThe Lancet, 2009
Haemopoietic-cell transplantation (HCT) is an intensive therapy used to treat high-risk haematological malignant disorders and other life-threatening haematological and genetic diseases. The main complication of HCT is graft-versus-host disease (GVHD), an immunological disorder that affects many organ systems, including the gastrointestinal tract ...
Ernst Holler   +3 more
openaire   +3 more sources

Graft-versus-host disease [PDF]

open access: yesJournal of the American Academy of Dermatology, 2012
Approximately 25,000 allogeneic hematopoietic cell transplants are performed worldwide each year for a variety of malignant and non-malignant conditions. Graft-versus-host disease represents one of the most frequent complications and is a major source of long-term morbidity and mortality.
Amin M. Alousi   +2 more
openaire   +8 more sources

Graft versus host disease [PDF]

open access: yesJournal of the American Academy of Dermatology, 1981
Graft versus host disease (GVHD) occurs in 50% to 70% of patients receiving bone marrow transplants. It can also develop in immunosuppressed patients with malignancies who receive nonirradiated blood transfusions. Most work indicates that the primary mechanism of GVHD is cell-mediated. It is likely that humoral factors are involved as well.
openaire   +5 more sources

Home - About - Disclaimer - Privacy